|Articles|January 1, 2012
- BioPharm International-01-01-2012
- Volume 25
- Issue 1
BioPharm International, January 2012 Issue (PDF)
Therapeutic Vaccines
Advertisement
Articles in this issue
about 14 years ago
Auditing by the Numbersabout 14 years ago
Here's to a Year of Compromiseabout 14 years ago
USAID Moves Global Healthcare Initiatives Forwardabout 14 years ago
Therapeutic Vaccine Outlookabout 14 years ago
Budget Crunch, Political Battles Shape Policy Agenda for Yearabout 14 years ago
A 25-Year Retrospective on Separations Technologyabout 14 years ago
Global Economic Woes Overshadow Biotech Industry Advances in 2011Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5
